Healthway Medical Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Healthway Medical has been growing earnings at an average annual rate of 73.9%, while the Healthcare industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 9.2% per year. Healthway Medical's return on equity is 4.2%, and it has net margins of 5.4%.
Belangrijke informatie
73.9%
Groei van de winst
74.5%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 9.2% |
| Rendement op eigen vermogen | 4.2% |
| Nettomarge | 5.4% |
| Laatste winstupdate | 30 Jun 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Healthway Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 23 | 161 | 9 | 0 | 0 |
| 31 Mar 23 | 160 | 11 | 0 | 0 |
| 31 Dec 22 | 160 | 13 | 0 | 0 |
| 30 Sep 22 | 157 | 13 | 0 | 0 |
| 30 Jun 22 | 154 | 13 | 0 | 0 |
| 31 Mar 22 | 147 | 12 | 0 | 0 |
| 31 Dec 21 | 140 | 11 | 0 | 0 |
| 30 Sep 21 | 129 | 10 | 0 | 0 |
| 30 Jun 21 | 118 | 9 | 0 | 0 |
| 31 Mar 21 | 108 | 6 | 1 | 0 |
| 31 Dec 20 | 97 | 3 | 1 | 0 |
| 30 Sep 20 | 101 | 1 | 2 | 0 |
| 30 Jun 20 | 105 | -2 | 2 | 0 |
| 31 Mar 20 | 110 | -2 | 2 | 0 |
| 31 Dec 19 | 114 | -3 | 1 | 0 |
| 30 Sep 19 | 112 | -7 | 4 | 0 |
| 30 Jun 19 | 111 | -8 | 7 | 0 |
| 31 Mar 19 | 111 | -7 | 9 | 0 |
| 31 Dec 18 | 113 | -6 | 12 | 0 |
| 30 Sep 18 | 114 | -30 | 13 | 0 |
| 30 Jun 18 | 113 | -31 | 12 | 0 |
| 31 Mar 18 | 110 | -34 | 12 | 0 |
| 31 Dec 17 | 105 | -35 | 12 | 0 |
| 30 Sep 17 | 98 | -51 | 53 | 0 |
| 30 Jun 17 | 97 | -48 | 51 | 0 |
| 31 Mar 17 | 95 | -45 | 48 | 0 |
| 31 Dec 16 | 98 | -44 | 46 | 0 |
| 30 Sep 16 | 99 | 0 | 13 | 0 |
| 30 Jun 16 | 96 | -3 | 13 | 0 |
| 31 Mar 16 | 97 | -1 | 13 | 0 |
| 31 Dec 15 | 95 | 2 | 13 | 0 |
| 30 Sep 15 | 92 | 0 | 14 | 0 |
| 30 Jun 15 | 91 | 13 | 14 | 0 |
| 31 Mar 15 | 87 | 12 | 14 | 0 |
| 31 Dec 14 | 86 | 10 | 14 | 0 |
| 30 Sep 14 | 84 | 9 | 23 | 0 |
| 30 Jun 14 | 83 | 8 | 23 | 0 |
| 31 Mar 14 | 82 | 30 | 23 | 0 |
| 31 Dec 13 | 81 | 31 | 23 | 0 |
| 30 Sep 13 | 82 | 37 | 9 | 0 |
| 30 Jun 13 | 82 | 28 | 9 | 0 |
| 31 Mar 13 | 82 | 7 | 9 | 0 |
| 31 Dec 12 | 82 | 8 | 9 | 0 |
Kwaliteitswinsten: 5NG has high quality earnings.
Groeiende winstmarge: 5NG's current net profit margins (5.4%) are lower than last year (8.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 5NG has become profitable over the past 5 years, growing earnings by 73.9% per year.
Versnelling van de groei: 5NG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 5NG had negative earnings growth (-32.7%) over the past year, making it difficult to compare to the Healthcare industry average (4.4%).
Rendement op eigen vermogen
Hoge ROE: 5NG's Return on Equity (4.2%) is considered low.